Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SL650472 (Trelanserin) in Intermittent Claudication (MASCOT)
NCT00300339Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of SL65.0472 in intermittent claudication (IC), sponsored by Sanofi. Started Feb 2006; status: completed.
02
Drugs
SL65.0472
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00300339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300339.